Disclosures for "Characterization, Evaluation, Diagnosis, and Treatment of Tumor-related Aphasia: A Scoping Review"
-
Mr. Finnemore has nothing to disclose.
-
Miss Paulino has nothing to disclose.
-
Mr. Miller has received personal compensation for serving as an employee of Hillsdale College.
-
Mr. Vinh has received research support from National Cancer Institute. Mr. Vinh has received research support from University of Virginia.
-
Dr. Maguire has received research support from Baker Family Initiative for Transforming Patient Experience and Outcomes at MGH. The institution of Dr. Maguire has received research support from NIMH. Dr. Maguire has received research support from NICHD.
-
Prof. Patel has nothing to disclose.
-
Dr. Caplan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for matteuzzi. Dr. Caplan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Matteuzzi Law.
-
Ms. Wade has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ConcertAI. Dr. Wright has received personal compensation in the range of $0-$499 for serving as a Consultant for Cancer Support Community. Dr. Wright has stock in Microsoft. The institution of Dr. Wright has received research support from National Cancer Institute.
-
The institution of Dr. Lindvall has received research support from National Institutes of Health.
-
Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from American Academy of Neurology. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.